High-Quality Graves’ Disease PBMC Research

Graves’ Disease Human PBMC products are sourced from donors clinically diagnosed with Graves’ Disease and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies on immune dysregulation, cytokine response, and therapeutic screening for Graves’ Disease-related inflammation.

Product Features

• Research Use Only (RUO), cryopreserved PBMCs
• Clinically confirmed Graves’ Disease donors
• Available in cell counts ranging from 5 million to 2 billion
• Processed within 24 hours of collection
• Stored using CryoStore® CS10 freezing media
• IRB-approved protocols and electronic informed consent
• Screen LeukoLot™ available prior to bulk orders

Donor Metadata

• Verified Graves’ Disease diagnosis
• Donor demographics: age, sex assigned at birth, race/ethnicity
• Self-reported allergies and infectious disease history
• Additional Graves’ Disease-specific data available upon request

Applications

• Biomarker discovery and validation
• Drug screening and therapeutic development
• Immune pathway analysis in Graves’ Disease pathophysiology
• Transcriptomic and proteomic profiling

Quality and Compliance

• IRB-approved collections and protocols
• 21 CFR Part 11 – compliant e-consent system
• HIPAA-compliant donor data protection

Ordering & Shipping

Graves’ Disease PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact to confirm documentation and compliance needs.